Agenda – 2019 Drug Pricing and Reimbursement Stakeholder Summit

  • Day One
  • Day Two

Day One

 Monday, July 15

9:15AM – 10:00AM

EXPLORE CHANGES TO THE POLICY LANDSCAPE THROUGH AN OVERVIEW OF MOST PREVALENT STATE TRANSPARENCY LAWS
Kendra Martello, Senior Director, Public Policy, MALLINCKRODT PHARMACEUTICALS

10:45AM – 11:15AM

NETWORKING BREAK

11:15AM – 12:15PM

PANEL DISCUSSION: MULTI-STAKEHOLDER INPUT ON VALUE-BASED AGREEMENTS BEST PRACTICES
John Alter, VP, Patient and Health Impact Lead, Hospital Business Unit, PFIZER

12:15PM – 1:15PM

LUNCHEON

1:15PM – 2:00PM

A BLUEPRINT TO COLLABORATION WITH PROVIDERS AND PAYERS — JOIN FORCES ON PRICING AND REIMBURSEMENT MATTERS
Stuart Levine MD MHA, Chief Medical and Innovation Officer, AGILON HEALTH

2:00PM – 2:45PM

LEGAL PERSPECTIVE: FEDERAL INITIATIVE IMPLICATIONS ON TRANSPARENCY — DISCUSS STATUS, IMPLEMENTATION, AND ENFORCEMENT OF STATE-BY-STATE REQUIREMENTS
To learn more about sponsorship opportunities, please contact Shauna Greig, Business Development Manager, at 212-400-6228 or sgreig@questex.com.

2:45PM – 3:15PM

NETWORKING BREAK

3:15PM – 4:00PM

THE EFFECT OF STRATEGIC PRACTICES WITHIN HEOR UPON VALUE-BASED PRICING AND REIMBURSEMENT MATTERS
Boxiong Tang, M.D., Senior Director, Health Economics and Outcomes Research (HEOR), BEIGENE, LTD

4:00PM – 5:00PM

EXPLORE THE OPERATIONAL COMPONENT OF THE DRUG PRICING TRANSPARENCY LAWS AND DISCUSS ITS IMPLICATIONS ON DEPARTMENTAL PROCEDURES
Deborah Walters, Vice President and Assistant General Counsel, PFIZER
Keren Tenenbaum, Assistant General Counsel, PFIZER


Day Two

 Tuesday, July 16

9:15AM – 10:15AM

DEBATE SIMULATION: UNDERSTAND REIMBURSEMENT THROUGH BOTH A MANUFACTURER AND A PAYER PERSPECTIVE IN ORDER TO BUILD STRONG RELATIONSHIPS
Jeff Krol, Vice President Market Access and Payer Strategy, GREENWICH BIOSCIENCES

10:15AM – 11:15AM

PANEL DISCUSSION: EXPLORE DRUG PRICING STATE TRANSPARENCY LAWS FROM A MULTI-STAKEHOLDER PERSPECTIVE
Kendra Martello, Senior Director, Public Policy, MALLINCKRODT PHARMACEUTICALS

11:45AM – 12:30PM

A PATIENT FOCUS: HOW TO ENSURE PATIENT ACCESS TO CRITICAL MEDICINES IN A CHANGING POLICY ENVIRONMENT
Mallory O’Connor, Director, Healthcare Policy and Federal Programs, BIOTECHNOLOGY INNOVATION ORGANIZATION-BIO

12:30PM – 1:30PM

LUNCHEON

3:00PM –

SUMMIT CONCLUDES